Federated Hermes’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $719K | Sell |
|
|||||
|
2021
Q1 | $757K | Sell |
|
|||||
|
2020
Q4 | $1.51M | Sell |
|
|||||
|
2020
Q3 | $23.6M | Buy |
|
|||||
|
2020
Q2 | $16.6M | Sell |
|
|||||
|
2020
Q1 | $17.5M | Buy |
|
|||||
|
2019
Q4 | $12M | Buy |
|
|||||
|
2019
Q3 | $8.75M | Buy |
|
|||||
|
2019
Q2 | $442K | Sell |
|
|||||
|
2019
Q1 | $2.25M | Buy |
|
|||||
|
2018
Q4 | $1.37M | Buy |
|
|||||
|
2018
Q3 | $1.33M | Sell |
|
|||||
|
2018
Q2 | $1.96M | Sell |
|
|||||
|
2018
Q1 | $2.96M | Sell |
|
|||||
|
2017
Q4 | $23.2M | Sell |
|
|||||
|
2017
Q3 | $80M | Sell |
|
|||||
|
2017
Q2 | $76.8M | Buy |
|
|||||
|
2017
Q1 | $68.4M | Sell |
|
|||||
|
2016
Q4 | $70.7M | Buy |
|
|||||
|
2016
Q3 | $64.4M | Buy |
|
|||||
|
2016
Q2 | $58.4M | Buy |
|
|||||
|
2016
Q1 | $65.7M | Buy |
|
|||||
|
2015
Q4 | $89.4M | Buy |
|
|||||
|
2015
Q3 | $68.6M | Buy |
|
|||||
|
2015
Q2 | $68.8M | Buy |
|
|||||
|
2015
Q1 | $7.56M | Sell |
|
|||||
|
2014
Q4 | $29.2M | Buy |
|
|||||
|
2014
Q3 | $25.7M | Sell |
|
|||||
|
2014
Q2 | $24.5M | Buy |
|
|||||
|
2014
Q1 | $20.8M | Buy |
|
|||||
|
2013
Q4 | $7.57M | Buy |
|
|||||
|
2013
Q3 | $6.3M | Buy |
|
|||||
|
2013
Q2 | $4.94M | Buy |
|